Feasibility
Decide whether the protocol fits the patients, people, workflow, budget, and capacity the site actually has.
Clinical trial site feasibility guide →Merindale is built for research leaders who do not need another high-level assessment. They need an experienced partner who understands how a study actually runs at the site, listens to the people doing the work, and helps the team change the system around them.
Start with evidence and the people closest to the work: study data, timelines, monitoring actions, staffing, handoffs, workflow, and lived operating experience. Separate the symptom from the constraint.
Work with the owners of the process to change the smallest set of things that can materially improve execution: ownership, sequence, measurement, escalation, or participant flow.
Leave the team with a rhythm it can sustain: clear measures, role ownership, review rhythm, documentation, and a shared understanding of how the new workflow should run.
The protocol is only one part of trial performance.
At the site, performance is shaped by feasibility decisions, activation dependencies, clinic-to-research handoffs, coordinator workload, monitoring follow-up, regulatory discipline, participant communication, and data quality.
Merindale's approach is informed by site-side clinical research experience across that lifecycle, including oncology and complex studies, investigator-initiated and sponsor-supported research, sponsor/CRO coordination, monitoring and quality workflows, data capture, budgets and contracts, close-out, and portfolio operations.
That range matters because the problem visible in one part of a study often originates somewhere else. A weak feasibility decision can become a startup delay. A clinic handoff can become an enrollment miss. A repeated monitoring finding can be a workflow problem rather than a training problem.
Merindale keeps the senior person close to the work while making the client's internal team part of the diagnosis and design. The goal is not outside dependency; it is a stronger operating rhythm inside the organization.
One study, one workflow, one portfolio issue, or one readiness objective at a time.
The people who run the process help shape the recommendation, because they are the ones who must make it work in practice.
Use actual timelines, screening paths, monitoring actions, workload, and process data before changing the system.
The end state is a clearer internal system with ownership, measures, and documentation the team can sustain.
The method is informed by hands-on site-side clinical research experience across feasibility, activation, enrollment, quality, monitoring follow-up, team operations, and the study lifecycle. Merindale does not present that prior individual experience as company tenure or completed Merindale projects.
Our Insights library shows how the same method applies to feasibility, enrollment, monitoring follow-up, and site workflow.
Decide whether the protocol fits the patients, people, workflow, budget, and capacity the site actually has.
Clinical trial site feasibility guide →Measure identification, screening, approach, consent, and enrollment separately so the real loss point becomes visible.
GU trial screening and enrollment guide →Turn monitoring findings into owned actions, evidence of correction, thoughtful CAPA decisions, and effectiveness checks.
Monitoring follow-up and CAPA guide →Find waiting time between teams before adding tools, meetings, or extra effort to the process.
Clinical trial site workflow guide →Read our professional standards and collaboration principles →
Bring one concrete problem. We will listen first, explain how we would investigate it, and tell you candidly whether Merindale is the right fit.